Position in BIIB
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$32,841
+$4,975 QoQ
Shares Held
152
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#848
of 1,031 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OGOREK ANTHONY JOSEPH /NY/ /ADV holds $11,041,030 across 10 Drug Manufacturers - General names. BIIB ranks #8 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,159 | $9,786,150 | |
| 2 | ABBV |
AbbVie Inc.
|
1,878 | $472,579 | |
| 3 | JNJ |
Johnson & Johnson
|
1,205 | $306,033 | |
| 4 | AMGN |
Amgen Inc
|
372 | $134,708 | |
| 5 | MRK |
Merck & Co., Inc.
|
980 | $125,930 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,392 | $80,207 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
463 | $58,495 | |
| 8 | BIIB |
Biogen Inc.
This page
|
152 | $32,841 |
All Filings in BIIB
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,841 | 152 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $27,866 | 152 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $26,750 | 152 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $24,093 | 172 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $21,601 | 172 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $9,031 | 66 | Shares | Sole | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||